TY - JOUR
T1 - Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
AU - Huynh-Le, Minh Phuong
AU - Fan, Chun Chieh
AU - Karunamuni, Roshan
AU - Thompson, Wesley K.
AU - Martinez, Maria Elena
AU - Eeles, Rosalind A.
AU - Kote-Jarai, Zsofia
AU - Muir, Kenneth
AU - Schleutker, Johanna
AU - Pashayan, Nora
AU - Batra, Jyotsna
AU - The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium
AU - Grönberg, Henrik
AU - Neal, David E.
AU - Donovan, Jenny L.
AU - Hamdy, Freddie C.
AU - Martin, Richard M.
AU - Nielsen, Sune F.
AU - Nordestgaard, Børge G.
AU - Wiklund, Fredrik
AU - Tangen, Catherine M.
AU - Giles, Graham G.
AU - Wolk, Alicja
AU - Albanes, Demetrius
AU - Travis, Ruth C.
AU - Blot, William J.
AU - Zheng, Wei
AU - Sanderson, Maureen
AU - Stanford, Janet L.
AU - Mucci, Lorelei A.
AU - West, Catharine M.L.
AU - Kibel, Adam S.
AU - Cussenot, Olivier
AU - Berndt, Sonja I.
AU - Koutros, Stella
AU - Sørensen, Karina Dalsgaard
AU - Cybulski, Cezary
AU - Grindedal, Eli Marie
AU - Menegaux, Florence
AU - Khaw, Kay Tee
AU - Park, Jong Y.
AU - Ingles, Sue A.
AU - Maier, Christiane
AU - Hamilton, Robert J.
AU - Thibodeau, Stephen N.
AU - Rosenstein, Barry S.
AU - Lu, Yong Jie
AU - Watya, Stephen
AU - Vega, Ana
AU - Kogevinas, Manolis
AU - Penney, Kathryn L.
AU - Huff, Chad
AU - Teixeira, Manuel R.
AU - Multigner, Luc
AU - Leach, Robin J.
AU - Cannon-Albright, Lisa
AU - Brenner, Hermann
AU - John, Esther M.
AU - Kaneva, Radka
AU - Logothetis, Christopher J.
AU - Neuhausen, Susan L.
AU - De Ruyck, Kim
AU - Pandha, Hardev
AU - Razack, Azad
AU - Newcomb, Lisa F.
AU - Fowke, Jay H.
AU - Gamulin, Marija
AU - Usmani, Nawaid
AU - Claessens, Frank
AU - Gago-Dominguez, Manuela
AU - Townsend, Paul A.
AU - Bush, William S.
AU - Roobol, Monique J.
AU - Parent, Marie Élise
AU - Hu, Jennifer J.
AU - Mills, Ian G.
AU - Andreassen, Ole A.
AU - Dale, Anders M.
AU - Seibert, Tyler M.
PY - 2021/2/23
Y1 - 2021/2/23
N2 - Genetic models for cancer have been evaluated using almost exclusively European data, which could exacerbate health disparities. A polygenic hazard score (PHS1) is associated with age at prostate cancer diagnosis and improves screening accuracy in Europeans. Here, we evaluate performance of PHS2 (PHS1, adapted for OncoArray) in a multi-ethnic dataset of 80,491 men (49,916 cases, 30,575 controls). PHS2 is associated with age at diagnosis of any and aggressive (Gleason score ≥ 7, stage T3-T4, PSA ≥ 10 ng/mL, or nodal/distant metastasis) cancer and prostate-cancer-specific death. Associations with cancer are significant within European (n = 71,856), Asian (n = 2,382), and African (n = 6,253) genetic ancestries (p < 10−180). Comparing the 80th/20th PHS2 percentiles, hazard ratios for prostate cancer, aggressive cancer, and prostate-cancer-specific death are 5.32, 5.88, and 5.68, respectively. Within European, Asian, and African ancestries, hazard ratios for prostate cancer are: 5.54, 4.49, and 2.54, respectively. PHS2 risk-stratifies men for any, aggressive, and fatal prostate cancer in a multi-ethnic dataset.
AB - Genetic models for cancer have been evaluated using almost exclusively European data, which could exacerbate health disparities. A polygenic hazard score (PHS1) is associated with age at prostate cancer diagnosis and improves screening accuracy in Europeans. Here, we evaluate performance of PHS2 (PHS1, adapted for OncoArray) in a multi-ethnic dataset of 80,491 men (49,916 cases, 30,575 controls). PHS2 is associated with age at diagnosis of any and aggressive (Gleason score ≥ 7, stage T3-T4, PSA ≥ 10 ng/mL, or nodal/distant metastasis) cancer and prostate-cancer-specific death. Associations with cancer are significant within European (n = 71,856), Asian (n = 2,382), and African (n = 6,253) genetic ancestries (p < 10−180). Comparing the 80th/20th PHS2 percentiles, hazard ratios for prostate cancer, aggressive cancer, and prostate-cancer-specific death are 5.32, 5.88, and 5.68, respectively. Within European, Asian, and African ancestries, hazard ratios for prostate cancer are: 5.54, 4.49, and 2.54, respectively. PHS2 risk-stratifies men for any, aggressive, and fatal prostate cancer in a multi-ethnic dataset.
UR - http://www.scopus.com/inward/record.url?scp=85101701053&partnerID=8YFLogxK
U2 - 10.1038/s41467-021-21287-0
DO - 10.1038/s41467-021-21287-0
M3 - Article
C2 - 33623038
AN - SCOPUS:85101701053
SN - 2041-1723
VL - 12
SP - 1
EP - 9
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 1236
ER -